Breaking Endocrinology News

(MedPage Today) -- Smoking may provide an explanation for reduced fertility, results of two studies suggested.

On July 15 (MedPage Today) -- a day after the FDA completed two days of hearings on rosiglitazone (Avandia) -- a British advisory commission on drugs concluded that the product should be withdrawn from the market, according to an investigation conducted by BMJ.

(MedPage Today) -- A second look at British registry data indicates that esophageal cancer may be more common after all in patients taking oral bisphosphonate drugs for long periods.

(MedPage Today) -- While a physician's decision to start a child on growth hormone is usually consistent with evidence-based guidelines, continuation or intensification of therapy is strongly influenced by factors other than treatment response, according to a new survey.

(MedPage Today) -- Overweight patients with cardiovascular risks who took the weight-loss drug sibutramine had an increased likelihood of experiencing a cardiac event, a large randomized trial found.

STOCKHOLM (MedPage Today) -- In this MedPage Today exclusive InFocus video report, the president of the American Heart Association takes the temperature of the first group of Hot Line trials reported here at the European Society of Cardiology congress.

STOCKHOLM (MedPage Today) -- Adding margarine enriched with omega-3 fatty acids as a dietary intervention did not prevent second heart attacks in older men and women at risk for worsening heart disease, researchers said here.

(MedPage Today) -- Insulin resistance and type 2 diabetes may contribute to the development of one type of brain plaque linked to Alzheimer's disease, according to an autopsy study.

(MedPage Today) -- The diabetes drug pioglitazone (Actos) carries cardiac risk similar to that found for embattled sister compound rosiglitazone (Avandia), according to an analysis of an administrative claims database.

(MedPage Today) -- Increasing the daily intake of green leafy vegetables could significantly reduce the risk of type 2 diabetes, a British meta-analysis found.